For the quarter ending 2025-09-30, ELAB had $2,017,934 increase in cash & cash equivalents over the period. -$1,585,761 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Change in fair value of derivative liabilities | - | 0 |
| Net loss | -2,594,320 | -2,170,810 |
| Depreciation and amortization | 35,284 | 1,622 |
| Finance cost | 179,479 | - |
| Share-based compensation | 13,179 | -42,996 |
| Straight-line rent expense | 30,403 | 230 |
| Accretion interest expense | - | 9,684 |
| Non-cash interest expense | 27,081 | - |
| Research and development costs for intangible assets | 0 | 14,358 |
| Gain on termination of intangible asset | 0 | 129,613 |
| Loss on the sale of skincare | 0 | -39,676 |
| Realized loss on sale of investments | -25,871 | -371,494 |
| Unrealized gain on investments | -230,461 | 238,899 |
| Receivables | -22,662 | 104,473 |
| Prepaid expenses and deposits | -73,883 | -120,999 |
| Inventory | -101,531 | -22,966 |
| Accounts payable and accrued liabilities | 434,809 | -169,268 |
| Customer deposits | 0 | -20,496 |
| Due to related parties | 0 | -397,728 |
| Cash flows used in operating activities | -1,490,167 | -2,693,714 |
| Purchase of equipment | 95,594 | 0 |
| Purchase of investments | 568,959 | 995,100 |
| Proceeds from sale of investments | 136,307 | 1,109,921 |
| Issuance of promissory note | 0 | 127,300 |
| Purchase of intangible assets | 0 | 6,000 |
| Net cash paid in business combinations | 1,669,787 | - |
| Cash flows used in investing activities | -2,198,033 | -18,479 |
| Issuance of common shares under atm agreement | - | 1,519,437 |
| Exercise of series a warrants, net | -240,714 | 1,938,772 |
| Share issuance costs | - | 531,290 |
| Proceeds from the registered direct offering, net | 1,245,306 | - |
| Repurchase of shares and warrants | 0 | 179 |
| Issuance of common stock under atm agreement, net | 1,672,104 | - |
| Exercise of replacement warrants, net | 27,415 | 1,484,028 |
| Proceeds from the initial pre-paid purchase of eloc, net | 3,990,007 | - |
| Cash flows provided by financing activities | 5,705,971 | 4,410,768 |
| Effect of exchange rate changes on cash | 163 | -400 |
| Increase(decrease) in cash | 2,017,934 | 1,698,175 |
| Cash and cash equivalents at beginning of period | 3,984,453 | - |
| Cash and cash equivalents at end of period | 7,700,562 | - |
PMGC Holdings Inc. (ELAB)
PMGC Holdings Inc. (ELAB)